Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...

GLP-1 receptor agonists may have beneficial effects against Alzheimers, psychiatric and addiction disorders, but early data ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded ...

A recent retrospective study published in the Frontiers in Endocrinology suggests that glucagon-like peptide-1 receptor ...

Use of injectable weight loss GLP-1 receptor agonists and the challenges this can pose when prescribing contraception or HRT ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Glucagon-like peptide-1 receptor agonists (GLP-1RA) are widely prescribed for Type 2 diabetes and obesity owing to their ...

The endocannabinoid system is one of the most diffuse neurotransmitter systems in the body and the brain. Understanding its ...